OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
December 07, 2022
In this episode of the Drug Solutions Podcast, Chris Spivey interviews executives at Shabas Solutions LLC, who ran the overseas QMM pilot project.
December 03, 2022
Overall industry growth conceals growing numbers of smaller, faster-paced, adaptable corporate structures.
November 17, 2022
CellVax Therapeutics has selected Theragent, a new CDMO, to manufacture clinical trial material for a new Phase II prostate cancer immunotherapy drug candidate.
November 08, 2022
Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.
November 02, 2022
In this article, the potential pitfalls of technology transfers are discussed as well as ways to ensure a smooth transition.
Industry experts discuss best practices for certificates of analysis.
Steriline will be exhibiting its vial filling and capping machine (VFCM100) under double-wall isolator for aseptic filling at CPHI 2022 in Frankfurt, Germany, on Nov. 1–3, 2022.
November 01, 2022
The company is expanding its contract development and manufacturing services for parenteral drugs to global customers.
October 31, 2022
The CPHI Annual Report 2022 predicts cash reserves from venture capitalists and private equities will drive expansion in the demand for contract research organizations and contract development and research organizations.
October 25, 2022
Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.
